期刊文献+

UPLC-MS/MS法测定人血浆中丙硫氧嘧啶的含量 被引量:1

Determination of propylthiouracil in human plasma by UPLC-MS/MS
下载PDF
导出
摘要 目的建立UPLC-MS/MS法测定人血浆中丙硫氧嘧啶的含量,为临床治疗药物监测(TDM)和生物等效性试验(BE)提供方法学基础。方法采用Agilent SB-C18柱(4.6 mm×150 mm,5μm),流动相为甲醇-0.1%甲酸水溶液(80∶20,V/V),等度洗脱。质谱采用AJS-ESI源,多反应监测(MRM)正离子模式,检测离子对为:丙硫氧嘧啶m/z 171.1→112.1、内标(丙硫氧嘧啶-D5)m/z 176.1→117.0。结果血浆中丙硫氧嘧啶在10~5 000 ng/ml范围内线性关系良好,r=0.999 3;批内和批间的精密度和准确度良好(RSD<10%,RE<±10%);不同浓度的基质效应均<110%,变异系数<5%;不同浓度的平均回收率为101.60%~113.56%,符合方法学要求。结论该方法快速简便、灵敏准确,适用于血浆中丙硫氧嘧啶的含量测定。 Objective To establish a method for the determination of propylthiouracil in human plasma by UPLCMS/MS and provide methodological basis for therapeutic drug monitoring(TDM) and bioequivalence test(BE) in clinical. Methods The chromatographic separation was performed on an Agilent SB-C18 column(4.6 mm×150 mm, 5 μm), the mobile phase was methanol and water containing 0.1% formic acid(80∶20, V/V), isocratic elution. MS condition was optimized in the positive ion detection mode by multiple reaction monitoring(MRM), along with the Agilent JetStream electrospray source interface(AJS-ESI).The precursors to the product ion transitions were m/z 171.1→112.1 for propylthiouracil and m/z 176.1→117.0 for the internal standard(IS). Results The calibration curve was linear in the range of 10-5 000 ng/ml for propylthiouracil in human plasma,r=0.999 3. The intra-day and inter-day precision and accuracy were good(RSD<10%,RE<±10%). The matrix effect of different concentrations was less than 110% and the coefficient of variation was less than 5%. The average recovery of different concentrations was 101.60%-113.56%, which conformed with the requirement of methodological validation. Conclusion The method is rapid, sensitive and accurate, which can be used for the determination of propylthiouracil in human plasma.
作者 李群英 凌琳 李盛建 周瑾 李甜甜 赵亮 吕磊 LI Qunying;LING Lin;LI Chengjian;ZHOU Jin;LI TianTian;ZHAO Liang;LÜ Lei(Department of Pharmacy,Shanghai Baoshan Luodian Hospital,Shanghai 201908,China;College of Traditional Chinese Medicine,Zhejiang University of Technology,Hangzhou 310014,China;Baoshan Dachang Community Health Center.Shanghai 200442,China;Department of Pharmacy,Shanghai Eastern Hepatobiliary Surgery Hospital,Shanghai 200438,China)
出处 《药学实践杂志》 CAS 2020年第4期350-353,378,共5页 Journal of Pharmaceutical Practice
关键词 超高效液相色谱-串联质谱 丙硫氧嘧啶 血浆 含量测定 UPLC-MS/MS propylthiouracil plasma content determination
  • 相关文献

参考文献7

二级参考文献35

  • 1梁隆科.原发性甲状腺功能亢进的彩色多普勒血流动力学评价[J].医学信息(医学与计算机应用),2014,0(6):72-73. 被引量:4
  • 2徐国宾,朱立华,李淑葵,刘静霞,夏铁安,李华,夏桂珠,高妍.HPLC测定初发甲亢病人体内丙基硫氧嘧啶药代动力学参数[J].中国药学杂志,1993,28(2):93-96. 被引量:6
  • 3M Benyounes,C Sempoux,C Daumerie,J Rahier,AP Geubel.Propylthiouracyl-induced severe liver toxicity:An indication for alanine aminotransferase monitoring?[J].World Journal of Gastroenterology,2006,12(38):6232-6234. 被引量:4
  • 4许曼音.甲状腺激素和抗甲状腺药[A].杨藻宸.药理学和药物治疗学,下册,第1版[M].北京:人民卫生出版社,2000.1246-1252.
  • 5International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man [ M ]. Lyon: International Agency for Research on Cancer, 1972.
  • 6U.S. Food and Drug Administration. Propyhhiouracil tablets, USP [ M]. (2015-02-11) [ 2015-02-15 ] http://www, accessdata, fda. gov/drugsaffda docs/label/2015/OO6188sO24161, pdf.
  • 7National Toxicology Program, Department of Health and Human Services. Propylthiouracil [ EB/OL ]. [ 2015-02-15 ]. http :// ntp. niehs, nih. gov/ntp/roc/content/profiles/propyhhiouracil, pdf.
  • 8McEvoy GK. AHFS Drug Information 2006 [ M ]. Bethesda: A- merican Society of Health-System Pharmacists, 2006: 3192.
  • 9Klaassen CD. Casarett & Doullg Toxicology: The Basic Science of Poisons[ M]. 6th ed. New York: McGraw-Hill, 2001 : 461.
  • 10Winters M J, Hurley RM, Lirenman DS. ANCA-positive glomeru- lonephritis and IgA nephropathy in a patient on propylthiouracil [J]. Pediatr Nephrol, 2002, 17(4) : 257-260.

共引文献43

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部